meclizine has been researched along with 2019 Novel Coronavirus Disease in 1 studies
Meclizine: A histamine H1 antagonist used in the treatment of motion sickness, vertigo, and nausea during pregnancy and radiation sickness.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Patients with coronavirus disease 2019 (COVID-19) commonly have manifestations of heart disease." | 1.72 | Genome-wide analyses reveal the detrimental impacts of SARS-CoV-2 viral gene Orf9c on human pluripotent stem cell-derived cardiomyocytes. ( Chen, H; Doud, EH; Guo, S; Han, L; Liu, J; Rubart-von der Lohe, M; Wan, J; Wang, C; Wu, S; Yang, L; Zhang, Y, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, J | 1 |
| Zhang, Y | 1 |
| Han, L | 1 |
| Guo, S | 1 |
| Wu, S | 1 |
| Doud, EH | 1 |
| Wang, C | 1 |
| Chen, H | 1 |
| Rubart-von der Lohe, M | 1 |
| Wan, J | 1 |
| Yang, L | 1 |
1 other study available for meclizine and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Genome-wide analyses reveal the detrimental impacts of SARS-CoV-2 viral gene Orf9c on human pluripotent stem cell-derived cardiomyocytes.
Topics: Action Potentials; Adenosine Triphosphate; Apoptosis; Coronavirus Nucleocapsid Proteins; COVID-19; D | 2022 |